Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
10/2005
10/13/2005WO2005095345A2 Heteroaryl guanidines as inhibitors of viral replication
10/13/2005WO2005095344A1 Thioalkeneamides as transketolase inhibitors
10/13/2005WO2005095339A1 Dicyanopyrrolidines as dipeptidyl peptidase iv inhibitors
10/13/2005WO2005095326A2 2-amino- and 2-thio-substituted 1,3-diaminopropanes
10/13/2005WO2005094805A1 Imine derivative and amide derivative
10/13/2005WO2005068468A3 Heterocyclic protein kinase inhibitors and uses thereof
10/13/2005WO2005066139A3 2-(amino-substituted)-4-aryl pyramidines and related compounds useful for treating inflammatory diseases
10/13/2005WO2005061458A3 Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
10/13/2005WO2004071447A9 Substituted azole derivatives as therapeutic agents
10/13/2005US20050228181 Serotonin receptor antagonists; nervous system disorders, R)-4-(2,3-dihydro-1,4-benzodioxin-5-yl)- beta -methyl-1-piperazineethanol
10/13/2005US20050228178 Process for the synthesis of 1,3,4,5-tetrahydro-2H-3-benzazepin-2-one compounds. and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
10/13/2005US20050228040 Bicyclic aromatic sulfinyl derivatives
10/13/2005US20050228036 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
10/13/2005US20050228034 treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease; for treating, ameliorating or preventing a CB1 receptor inverse-agonist mediated appetite related obesity related or metabolism related syndrome, disorder or disease
10/13/2005US20050228029 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, particularly those diseases related to thrombosis
10/13/2005US20050228024 Pharmaceutical compositions comprising a benzofuran derivative and their use for the treatment of attention deficit/hyperactivity disorder
10/13/2005US20050228022 blocking voltage-sensitive sodium channels of neurons in a mammal comprising administering 1-benzyl-2-imino-3-(2-hydroxy-3-phenoxypropyl)benzimidazole; analgesics; neuroprotectants; anticonvulsants
10/13/2005US20050228018 Chemical compounds
10/13/2005US20050228016 Tetrahydroquinolines for modulating the expression of exogenous genes via an ecdysone receptor complex
10/13/2005US20050228011 use of carboxy-functional benzofurans or benzothiophenes to treat tumor growth, metastasis, osteoporosis, restenosis, inflammation, macular degeneration, diabetic retinopathy, rheumatoid arthritis, and sickle cell anemia; greater bioavailability or fewer side-effects
10/13/2005US20050227992 Protein kinase inhibitors
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/13/2005US20050227976 Novel hydroxamates as therapeutic agents
10/13/2005US20050227962 Process for the synthesis of 1,3-dihydro-2H-3-benzazepin-2-one compounds, and to the application thereof in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
10/13/2005US20050224524 Aerosol
10/13/2005DE10393799T5 Kinaseinhibitoren für die Behandlung von Erkrankungen Kinase inhibitors for the treatment of diseases
10/13/2005DE102004015007A1 Substituierte Imidazole Substituted imidazoles
10/13/2005CA2562126A1 Pyrazine derivatives and pharmaceutical use thereof
10/13/2005CA2561441A1 Pyrazole-amine compounds for the treatment of neurodegenerative disorders
10/13/2005CA2561305A1 Tetrahydro-indazole cannabinoid modulators
10/13/2005CA2560773A1 2-amino- and 2-thio-substituted 1,3-diaminopropanes
10/13/2005CA2559945A1 Pyrazole compounds and uses related thereto
10/13/2005CA2558915A1 Pyrimidine derivatives and methods of treatment related to the use thereof
10/13/2005CA2557372A1 Diaminopyrimidines as p2x3 and p2x2/3 antagonists
10/12/2005EP1584619A1 Derivatives of quinoline as inhibitors for MEK
10/12/2005EP1584616A1 Industrial process for the production of crystalline atorvastatin trihydrate hemi calcium salt
10/12/2005EP1583972A2 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
10/12/2005EP1583759A1 Pyridine derivatives useful for inhibiting sodium/calcium exchange system
10/12/2005EP1583757A1 Novel substituted nitrogen-containing heterobicycles and use thereof as factor xa inhibitors
10/12/2005EP1583745A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
10/12/2005EP1583744A2 Substituted benzylamine derivatives and methods of use
10/12/2005EP1583742A1 Novel cb 1 receptour inverse agonists
10/12/2005EP1583741A1 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists
10/12/2005EP1482939A4 Preparation of paroxetine involving novel intermediates
10/12/2005EP1383763B1 Method for producing 2-(-5-(4-fluorophenyl)-3-pyridylmethylaminomethyl)-chromane
10/12/2005EP1201235B1 Neuropathy improvers containing nitrogenous compounds as the active ingredient
10/12/2005EP1177188B1 Pyrazole carboxamides useful for the treatment of obesity and other disorders
10/12/2005EP1060163B1 New piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides
10/12/2005EP1049676B1 4- aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor
10/12/2005EP0954522B1 Novel substituted naphthopyrans
10/12/2005EP0912547B1 New substituted pyridyl keto enols
10/12/2005CN1681830A Novel chemical substance having morphogenetic and growth-accelerating activities
10/12/2005CN1681807A Antidepressant cycloalkylamine derivatives of 2, 3-dihydro-1, 4-benzodioxan
10/12/2005CN1681805A Novel imidazole compounds as transforming growth factor (TGF) inhibitors
10/12/2005CN1681795A Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
10/12/2005CN1681788A COX-2 inhibiting pyridine derivatives
10/12/2005CN1681784A Azabicyclo derivatives as muscarinic receptor antagonists
10/12/2005CN1681763A Chemical compounds
10/12/2005CN1681557A Methods for treating carbonic anhydrase mediated disorders
10/12/2005CN1681502A Novel triazole compounds as transforming growth factors (TGF) inhibitors
10/12/2005CN1681501A Novel pyrazole compounds as transforming growth factor (TGF) inhibitors
10/12/2005CN1681498A Diaryl ethers as opioid receptor antagonist
10/12/2005CN1680369A Double ketole colorless benzofuryl ketone compound and its preparation
10/12/2005CN1680340A Novel triazolo pyrimidine compounds
10/12/2005CN1680338A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2005CN1680334A Fused pyrazolyls
10/12/2005CN1680324A Dihydropyridine soft drugs, and related compositions and methods
10/12/2005CN1680314A 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
10/12/2005CN1680274A Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them
10/12/2005CN1679612A Enantiomerically pure beta-d-dioxolane nucleosides with selective anti-hepatitus b virus activity
10/12/2005CN1679577A Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts
10/12/2005CN1679552A Preferential inhibition of release of pro-inflammatory cytokines
10/12/2005CN1222521C Proces for synthesis of 5-(4-fluorophenyl)-1-[2R, 4R]-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxypic acid phenylamide
10/12/2005CN1222291C Novel uses of combined 5-HT 1A agonists and serotonin reuptake inhibitor
10/11/2005US6953858 A phenylalkyl secondary- and tertiary-amides enzyme inhibitors as viricides, for treating AIDS
10/11/2005US6953857 Oxybenzamide derivatives useful for inhibiting factor Xa or viia
10/11/2005US6953853 Phospholipase inhbitors; antiinflammatory agents; respiratory system disorders
10/11/2005US6953810 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
10/11/2005US6953809 Monocyte chemoattractant protein-1 inhibitor compounds
10/11/2005US6953807 4-substituted-picolinic acid amide derivatives useful as fungicides
10/11/2005US6953800 Quinazoline derivatives
10/11/2005US6953798 compounds are able to inhibit binding of alpha 4 integrins to their ligands and are of use in prophylaxis and treatment of immune or inflammatory disorders
10/11/2005US6953789 a 3- or 4-Mercapto-1-(4-phenoxybenzyl)azepine-2-one; thioetherification with a mercaptan; matrix metalloprotease (MMP) inhibitors; antiarthritic, anticaries agent;
10/11/2005CA2341949C Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses
10/11/2005CA2282277C Atropisomers of 3-aryl-4(3h)-quinazolinones and their use as ampa-receptor antagonists
10/06/2005WO2005092995A1 Reversible piezochromic systems
10/06/2005WO2005092900A1 PROCESS FOR PREPARING CEPHALOSPORIN INTERMEDIATES USING α-IODO-1-AZETIDINEACETIC ACID ESTERS AND TRIALKYLPHOSPHITES
10/06/2005WO2005092885A1 4-amino-piperidine derivatives as monoamine uptake inhibitors
10/06/2005WO2005092884A1 Novel crystalline forms of conazoles and methods of making and using the same
10/06/2005WO2005092883A1 Process for preparing n-aryl-piperazine derivatives
10/06/2005WO2005092882A1 4-amino-5-halogeno-benzamide derivatives as 5-ht4 receptor agonists for the treatment of gastrointestinal, cns, neurological and cardiovascular disorders
10/06/2005WO2005092867A2 Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin
10/06/2005WO2005092865A1 Antiviral 4-aminocarbonylamino-substituted imidazole compound
10/06/2005WO2005092864A1 Imidazole compounds for the treatment of neurodegenerative disorders
10/06/2005WO2005092863A1 4-carbox pyrazole derivates useful as anti-viral agents
10/06/2005WO2005092854A1 Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators
10/06/2005WO2005092307A2 Pharmaceutical dosage forms and compositions of 5-ht1a receptor antagonists
10/06/2005WO2005091752A2 Acrylonitrile derivatives for inflammation and immune-related uses
10/06/2005WO2005073216A3 Hcv ns-3 serine protease inhibitors
10/06/2005WO2005056543A3 Process for use in the preparation of oxiranes from alkenes, and catalysts for use therein
1 ... 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 ... 694